Specialty
Interventional Cardiology devices
Last checked: Nov 19, 2026Source: openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
1,371
510(k), De Novo and PMA
Decisions, last 36 months
358
Recruiting device trials
155
Industry sponsored
Adverse event reports
65,599
Received Nov 1, 2025 to Nov 19, 2026
Part of
Latest FDA decisions
The 8 newest. A specialty is the FDA review panel, or a list of product codes for a narrower view.
- NeuroSheath510(k)
K261449 · Decided Nov 5, 2026 · 188 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K263678 · Decided Nov 5, 2026 · 29 days after receipt
Device type: Filter, Intravascular, Cardiovascular (DTK) · Cardiology
K260600 · Decided Nov 4, 2026 · 253 days after receipt
Device type: Temporary Carotid Catheter For Embolic Capture (NTE) · Cardiology
- Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic ProtectionPMA supplement
P240009-S006 · Decided Nov 4, 2026 · 401 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
- Parafleet NC 014 PTA Balloon Dilatation Catheter;Parafleet NC 018 PTA Balloon Dilatation Catheter510(k)
K262590 · Decided Nov 2, 2026 · 98 days after receipt
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT) · Cardiology
K262864 · Decided Oct 26, 2026 · 73 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
- Embrace(TM) Hydrogel Embolic SystemPMA supplement
P250003-S008 · Decided Oct 23, 2026 · 178 days after receipt · Panel Track
Device type: Embolization Agent, Vascular (QVG) · Cardiology
K260686 · Decided Oct 22, 2026 · 233 days after receipt
Device type: Catheter, Percutaneous, Cutting/Scoring (PNO) · Cardiology
FDA decisions per month
Last 36 months, by decision date and pathway.
- 510(k)
- De Novo
- PMA
View as table
| Month | 510(k) | De Novo | PMA |
|---|---|---|---|
| Dec 23 | 12 | 0 | 2 |
| Jan 24 | 4 | 0 | 1 |
| Feb 24 | 8 | 1 | 3 |
| Mar 24 | 9 | 0 | 0 |
| Apr 24 | 5 | 0 | 2 |
| May 24 | 12 | 0 | 1 |
| Jun 24 | 12 | 0 | 1 |
| Jul 24 | 10 | 0 | 0 |
| Aug 24 | 6 | 0 | 1 |
| Sep 24 | 10 | 1 | 0 |
| Oct 24 | 8 | 0 | 1 |
| Nov 24 | 4 | 0 | 1 |
| Dec 24 | 14 | 0 | 1 |
| Jan 25 | 10 | 0 | 1 |
| Feb 25 | 6 | 0 | 0 |
| Mar 25 | 12 | 0 | 0 |
| Apr 25 | 9 | 0 | 3 |
| May 25 | 15 | 1 | 3 |
| Jun 25 | 13 | 0 | 1 |
| Jul 25 | 5 | 0 | 2 |
| Aug 25 | 3 | 0 | 2 |
| Sep 25 | 4 | 0 | 0 |
| Oct 25 | 11 | 0 | 1 |
| Nov 25 | 4 | 0 | 0 |
| Dec 25 | 9 | 0 | 2 |
| Jan 26 | 8 | 0 | 0 |
| Feb 26 | 6 | 0 | 0 |
| Mar 26 | 6 | 0 | 2 |
| Apr 26 | 15 | 1 | 1 |
| May 26 | 8 | 0 | 0 |
| Jun 26 | 8 | 0 | 1 |
| Jul 26 | 14 | 0 | 1 |
| Aug 26 | 8 | 0 | 0 |
| Sep 26 | 13 | 0 | 1 |
| Oct 26 | 9 | 0 | 4 |
| Nov 26 | 4 | 0 | 1 |
Recruiting device trials
Industry-sponsored device trials that are recruiting now, most recently updated first.
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsPivotal-lookingRecruiting
Cleerly, Inc.Not on our public-company list
NCT06112418 · 7,500 participants (planned) · Start Mar 6, 2024 · Primary completion Mar 5, 2029
Device: The Cleerly CAD Staging System · For: Diabetes Mellitus, Type 2; PreDiabetes; Metabolic Syndrome
Sites: Chandler, Arizona; Scottsdale, Arizona; Sun City, Arizona · 125 sites in all
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)Pivotal-lookingRecruiting
Supira MedicalNot on our public-company list
NCT07296744 · 358 participants (planned) · Start May 11, 2026 · Primary completion Nov 2027
Device: The Supira System; Impella · For: Coronary Artery Disease; High Risk Percutaneous Coronary Intervention; Interventional Cardiology and 1 more
Sites: Loma Linda, California; Sacramento, California; Thousand Oaks, California · 27 sites in all
Imperative Care, Inc.Not on our public-company list
NCT07491952 · 750 participants (planned) · Start Mar 24, 2026 · Primary completion Mar 31, 2030
Device: Zoom System · For: Ischemic Stroke; Acute Stroke
Sites: Huntsville, Alabama; Walnut Creek, California; Tampa, Florida · 26 sites in all
Abbott Medical DevicesPublic (ABT)
NCT07798726 · 565 participants (planned) · Start Oct 21, 2026 · Primary completion Dec 31, 2031
Device: Cephea Mitral Valve System · For: Mitral Valve Disease; Mitral Annulus Calcification; Mitral Regurgitation and 6 more
Sites: Wichita, Kansas
- Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery LesionsPivotal-lookingRecruiting
TeleflexPublic (TFX)
NCT07258290 · 1,859 participants (planned) · Start Jun 11, 2026 · Primary completion Jun 2029
Device: Freesolve RMS; Xience DES · For: Coronary Disease; Heart Diseases; Cardiovascular Diseases and 12 more
Sites: Washington D.C., District of Columbia; Dallas, Texas; Plano, Texas · 7 sites in all
Abiomed Inc.Public (JNJ)
NCT06965504 · 250 participants (planned) · Start Oct 2, 2026 · Primary completion Dec 1, 2028
Device: Impella 5.5 SmartAssist · For: Heart Failure; Cardiogenic Shock; Reduced Ejection Fraction Heart Failure
Sites: Sacramento, California; San Francisco, California; Naples, Florida · 23 sites in all
How new technology gets paid for
Recent Medicare coverage decisions that touch this specialty.
Reports received
65,599
Received Nov 1, 2025 to Nov 19, 2026. Includes 119 of another or unstated type.
Malfunction reports
33,765
51% of reports
Injury reports
28,661
44% of reports
Death reports
3,054
4.7% of reports
Adverse event reports received per month
By the date FDA received each report. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Nov 25 | 2,574 | 2,065 | 164 | 2 |
| Dec 25 | 2,894 | 2,450 | 269 | 0 |
| Jan 26 | 3,579 | 2,156 | 317 | 0 |
| Feb 26 | 2,527 | 2,184 | 217 | 0 |
| Mar 26 | 2,932 | 3,402 | 495 | 1 |
| Apr 26 | 2,949 | 2,555 | 371 | 0 |
| May 26 | 2,636 | 2,272 | 212 | 0 |
| Jun 26 | 2,733 | 2,335 | 235 | 6 |
| Jul 26 | 2,983 | 2,436 | 238 | 9 |
| Aug 26 | 2,640 | 2,176 | 155 | 30 |
| Sep 26 | 2,674 | 2,295 | 176 | 34 |
| Oct 26 | 2,644 | 2,335 | 205 | 37 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types with the most reports
Widely used device types get more reports. This is not a ranking of safety.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0287-2027 · Started Oct 5, 2026 · Posted by FDA Nov 2, 2026
Reason given: Due to a manufacturing issue which may result in cardiovascular balloon rupturing.
Cause as FDA categorized it: Process change control · Device type: Prosthesis, Mitral Valve, Percutaneously Delivered (NPU)
Z-0213-2027 · Started Sep 24, 2026 · Posted by FDA Nov 2, 2026
Reason given: Kits contain infusion sets which were recalled for performance issues.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Angiography/Angioplasty Kit (OEQ)
Z-0191-2027 · Started Sep 10, 2026 · Posted by FDA Oct 16, 2026
Reason given: Changes to Instructions for Use (IFU) for the device regarding risk of Pulmonary Artery Injury (PAI).
Cause as FDA categorized it: Labeling design · Device type: System, Appendage Closure, Left Atrial (NGV)
- Medline surgical convenience kits labeled as: CABG AUXILIARY PACK, Medline Product Number/SKU DYNJ44925DOpen, Classified
Z-0168-2027 · Started Sep 2, 2026 · Posted by FDA Oct 15, 2026
Reason given: Medical convenience kits were distributed containing cannula components which do not conform to ISO 80369-7 dimensional requirements and may contribute to leaking or breaking during use.
Cause as FDA categorized it: Under Investigation by firm · Device type: Angiography/Angioplasty Kit (OEQ)
Z-0117-2027 · Started Aug 28, 2026 · Posted by FDA Oct 7, 2026
Reason given: Devices failed in process testing related to the amount of pull force it can sustain prior to the balloon components failing.
Cause as FDA categorized it: Under Investigation by firm · Device type: Catheter, Embolectomy (DXE)
Z-3214-2026 · Started Aug 24, 2026 · Posted by FDA Sep 23, 2026
Reason given: Tip may fracture or detach, leading to device fragments remaining within the patient or migrating through the vasculature. Patient impact may include prolonged procedure or life-threatening embolism.
Cause as FDA categorized it: Process control · Device type: Catheter, Intravascular, Diagnostic (DQO)
Z-3305-2026 · Started Aug 10, 2026 · Posted by FDA Sep 25, 2026
Reason given: Microspheres used in embolization of tumors, prostatic arteries, arteriovenous malformations, and blood vessels may have holes in packaging that may affect the sterile barrier, which if used could lead to infection.
Cause as FDA categorized it: Process control · Device type: Device, Vascular, For Promoting Embolization (KRD)
- JenaValve Trilogy Delivery Catheter, Size 23MM REF: TRILOGY-DC-SOpen, Classified
Z-0134-2027 · Started Jul 31, 2026 · Posted by FDA Oct 9, 2026
Reason given: Delivery Catheter may have sleeve liner separation that results in difficulty or inability to deploy heart valve device.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Showing the 8 newest of 2,338 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.